Abstract
The American College of Cardiology and American Heart Association have issued a "focused update" of their 2004 guidelines for the management of ST-segment elevation myocardial infarction (STEMI). Several of the issues addressed involve new data and new recommendations on treatment decisions that may be made in the emergency department. In this review, we present the new recommendations that are pertinent to emergency medicine practice and comment on their potential implementation into an evidence-based, multidisciplinary approach to the timely care of the STEMI patient.
MeSH terms
-
Angioplasty, Balloon, Coronary*
-
Cardiology*
-
Clopidogrel
-
Emergency Service, Hospital*
-
Enoxaparin / therapeutic use
-
Evidence-Based Medicine
-
Fibrinolytic Agents / therapeutic use*
-
Humans
-
Myocardial Infarction / drug therapy*
-
Myocardial Infarction / therapy*
-
Myocardial Reperfusion
-
Platelet Aggregation Inhibitors / classification
-
Platelet Aggregation Inhibitors / therapeutic use*
-
Randomized Controlled Trials as Topic
-
Societies, Medical*
-
Ticlopidine / analogs & derivatives*
-
Ticlopidine / therapeutic use
-
United States
Substances
-
Enoxaparin
-
Fibrinolytic Agents
-
Platelet Aggregation Inhibitors
-
Clopidogrel
-
Ticlopidine